TREA

90620821 - MEDICAGO UNLEASH THE POWER OF PLANTS

Follow

Information

  • Trademark
  • 90620821
  • Serial Number
    90620821
  • Registration Number
    6868840
  • Filing Date
    April 02, 2021
    3 years ago
  • Registration Date
    October 11, 2022
    a year ago
  • Transaction Date
    October 11, 2022
    a year ago
  • Status Date
    October 11, 2022
    a year ago
  • Published for Opposition Date
    July 26, 2022
    a year ago
  • Location Date
    October 11, 2022
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DAVIS, TRENTON MICHAEL
  • Attorney Docket Number
    SWA0565TUS
    Attorney Name
    Benjamin M. Cantor
    Law Office Assigned Location Code
    L90
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
MEDICAGO UNLEASH THE POWER OF PLANTS
Case File Statements
  • GS0401: Manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
  • GS0051: Pharmaceutical and medicinal preparations and substances, namely, human vaccines, therapeutic proteins and antibodies for the treatment of infectious diseases, chronic diseases and cancer
  • TF0000: as to "MEDICAGO"
  • GS0441: Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; Medical information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues and maintaining awareness of one's health; On-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
  • GS0421: Research and development in the field of human vaccines, recombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates; Medical information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; On-line information services, namely, providing medical research information to physicians, healthcare professionals and patients on the topics of diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies
Case File Event Statements
  • 10/11/2022 - a year ago
    20 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/11/2022 - a year ago
    19 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/26/2022 - a year ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/26/2022 - a year ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/6/2022 - a year ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/23/2022 - 2 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/22/2022 - 2 years ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/22/2022 - 2 years ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/22/2022 - 2 years ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/22/2022 - 2 years ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/2/2022 - 2 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/2/2022 - 2 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/2/2022 - 2 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 5/25/2022 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/26/2021 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/26/2021 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/26/2021 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/17/2021 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/11/2021 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 4/6/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP